Good quarterly report, appears to be progress on all fronts.
PharmAust has identified a Principal Investigator in the United States to evaluate the new MPL tablet in human Phase 2 cancer trials, as a follow on from the Phase I clinical trial undertaken at the Royal Adelaide Hospital in 2015.
So once we have the phase 1 data it should be full steam ahead into multiple phase 2 trials it would seem for covid, cancer, mnd…
Good quarterly report, appears to be progress on all fronts....
-
- There are more pages in this discussion • 39 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $86.55M | |||
| Open | High | Low | Value | Volume |
| 19.5¢ | 19.5¢ | 18.5¢ | $330.4K | 1.741M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4071 | 19.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 19.5¢ | 24580 | 3 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| PAA (ASX) Chart |